Opus Genetics (IRD) EBT (2010 - 2026)
Opus Genetics' (IRD) quarterly EBT came in at -$65.5 million in Q1 2026, down 699.79% year-on-year from $10.9 million in Q1 2025, and down 296.63% on a QoQ basis from -$16.5 million in Q4 2025.
Opus Genetics (IRD) EBT (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has 17 years of EBT data on file, last reported at -$65.5 million in Q1 2026.
- On a quarterly basis, EBT fell 699.79% year-over-year to -$65.5 million in Q1 2026; TTM through Mar 2026 was -$106.9 million, a 82.42% decrease from a year earlier, with the FY2025 full-year figure at -$49.6 million, up 13.8% from the prior year.
- EBT for Q1 2026 stood at -$65.5 million, down from -$16.5 million in the prior quarter.
- Over the last five years, EBT for IRD reached as high as $34.3 million in Q4 2022 and fell as low as -$65.5 million in Q1 2026.
- Historically, EBT has averaged -$9.7 million across 5 years, with a median of -$7.1 million in 2024.
- Across the five-year window, EBT soared 642.63% in 2022 and slumped 699.79% in 2026, its largest moves.
- Year by year, EBT stood at $34.3 million in 2022, then plunged by 114.0% to -$4.8 million in 2023, then plunged by 632.44% to -$35.1 million in 2024, then jumped by 52.97% to -$16.5 million in 2025, then slumped by 296.63% to -$65.5 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$65.5 million in Q1 2026, -$16.5 million in Q4 2025, and -$17.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | -65.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.54 Mn |
| Dec 31, 2025 | -16.52 Mn |
| Sep 30, 2025 | -17.45 Mn |
| Jun 30, 2025 | -7.42 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -35.14 Mn |
| Sep 30, 2024 | -7.53 Mn |
| Jun 30, 2024 | -7.77 Mn |
| Mar 31, 2024 | -7.11 Mn |
| Dec 31, 2023 | -4.80 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | -4.96 Mn |
| Mar 31, 2023 | -5.79 Mn |
| Dec 31, 2022 | 34.26 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.93 Mn |
| Mar 31, 2022 | -6.60 Mn |
| Dec 31, 2021 | -6.31 Mn |
| Sep 30, 2021 | -4.23 Mn |
| Jun 30, 2021 | -7.14 Mn |